longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SPDR S&P Biotech

XBI

----
Start trading
OverviewOverviewNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends
LongbridgeAI
  • Weekly Recap | Twist Bioscience +2%, consensus target below spot

    Weekly Review·Sep 12 at 07:00 AM
    TWST+2.49%
  • Weekly Recap | Roivant Sciences +16.86%, closing in on record highs

    Weekly Review·Sep 12 at 06:42 AM
    ROIV-3.71%
  • Weekly Recap | Revolution Medicines -2.98%, consensus target above spot

    Weekly Review·Sep 12 at 06:40 AM
    RVMD-0.12%
  • Weekly Recap | Natera +0.23%, consensus target above spot

    Weekly Review·Sep 12 at 06:29 AM
    NTRA+2.63%
  • Weekly Recap | Insmed +2.47%, consensus target above spot

    Weekly Review·Sep 12 at 06:06 AM
    INSM-4.29%
  • Weekly Recap | SPDR S&P Biotech -4.65%, most brokers rate it buy

    Weekly Review·Sep 12 at 05:07 AM
    XBI-2.27%LABD+6.48%
  • Weekly Recap | Natera +0.59%, closing in on record highs

    Weekly Review·Sep 5 at 07:41 AM
    NTRA+2.63%
  • Weekly Recap | SPDR S&P Biotech +0.88%, constituent names hit 52-week highs

    Weekly Review·Sep 5 at 04:31 AM
    XBI-2.27%
  • Weekly Recap | SPDR S&P Biotech -2.02%, sector split as FDA win lifts select names

    Weekly Review·Aug 29 at 04:01 AM
    XBI-2.27%
  • Weekly Recap | SPDR S&P Biotech +5.29%, AI and cancer vaccine catalysts fire up rally

    Weekly Review·Aug 22 at 06:32 AM
    XBI-2.27%